Inventor · disambiguated record
Maria Del Carmen Cuevas Marchante
Also filed as: CUEVAS MARCHANTE MARIA DEL CARMEN · CUEVAS MARCHANTE MARÍA DEL CARMEN
14 granted patents·8 pending applications·69 citations·filing 2006–2023
91Inventor score
Files withPHARMA MAR SA14MARTIN LOPEZ MA JESUS2RODRÍGUEZ VICENTE ALBERTO2FERNÁNDEZ RODRÍGUEZ ROGELIO1MARTIN LÓPEZ MA JESÚS1
Top patents by PatentIndex Score
22 records- 0194US11339180B2Antitumoral compoundsPHARMA MAR SA·Filed 2021·Granted May 24, 2022·3 cites·22 claims
- 0292US7683028B2Kahalalide compositionsPHARMA MAR SAU·Filed 2008·Granted Mar 23, 2010·11 cites·16 claims
- 0385US11332480B2Antitumoral compoundsPHARMA MAR SA·Filed 2018·Granted May 17, 2022·2 cites·20 claims
- 0483US12384800B2Antitumoral compoundsPHARMA MAR SA·Filed 2023·Granted Aug 12, 2025·0 cites·23 claims
- 0582US9428524B2Synthetic process for the manufacture of ecteinascidin compoundsMARTIN LÓPEZ MA JESÚS·Filed 2011·Granted Aug 30, 2016·7 cites·20 claims
- 0680US9187445B2Antitumoral compoundsRODRÍGUEZ VICENTE ALBERTO·Filed 2008·Granted Nov 17, 2015·7 cites·31 claims
- 0780US8710264B2Antitumoral compoundsRODRÍGUEZ VICENTE ALBERTO·Filed 2008·Granted Apr 29, 2014·7 cites·20 claims
- 0879US11713325B2Antitumoral compoundsPHARMA MAR SA·Filed 2022·Granted Aug 1, 2023·0 cites·22 claims
- 0979US8324406B2Antitumoral dihydropyran-2-one compoundsMARTIN LOPEZ MA JESUS·Filed 2007·Granted Dec 4, 2012·8 cites·37 claims
- 1078US9827257B2Antitumoral compoundsPHARMA MAR SA·Filed 2015·Granted Nov 28, 2017·5 cites·14 claims
- 1177US8501968B2Antitumoral dihydropyran-2-one compoundsMARTIN LOPEZ MA JESUS·Filed 2011·Granted Aug 6, 2013·6 cites·35 claims
- 1276US8748388B2Antitumoral compoundsTULLA-PUCHE JUDIT·Filed 2008·Granted Jun 10, 2014·7 cites·23 claims
- 1373US8962602B2Anticancer steroidal lactones unsaturated in position 7 (8)FERNÁNDEZ RODRÍGUEZ ROGELIO·Filed 2011·Granted Feb 24, 2015·6 cites·27 claims
- 1455US2025243174A1Antitumoral compoundsPHARMA MAR SA·Filed 2022·Application pending·0 cites
- 1553US2024131180A1Drug antibody conjugatesPHARMA MAR SA·Filed 2021·Application pending·0 cites
- 1652US2023218774A1Drug antibody conjugatesPHARMA MAR SA·Filed 2020·Application pending·0 cites
- 1750US2011237520A1Anticancer CompoundsPHARMA MAR SA·Filed 2009·Application pending·0 cites
- 1848US2011105409A1Anticancer CompoundsPHARMA MAR SA·Filed 2009·Application pending·0 cites
- 1948US2011118343A1Antitumoral MacrolidesPHARMA MAR SA·Filed 2009·Application pending·0 cites
- 2041US2009030068A1Antitumour CompoundsPHARMA MAR SA·Filed 2006·Application pending·0 cites
- 2138US2010216817A1Antitumoral Tetrahydro-PyrimidinesPHARMA MAR SA·Filed 2006·Application pending·0 cites
- 2236US12215100B2Anticancer compoundsPHARMA MAR SA·Filed 2019·Granted Feb 4, 2025·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →